Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment

Archives of Ophthalmology

Volumn 126, Issue 9, 2008, Pages 1311-1313

  Kuo, Irene C ^b   Haller, Julia A ^b   Maffrand, Roque ^b   Sambuelli, Ruben H ^b   Reviglio, Victor E ^a  

^a UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINATE CALCIUM; OXALIPLATIN;

AGED; BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER SURGERY; CASE REPORT; CHOROID CANCER; COLORECTAL CARCINOMA; FEMALE; HUMAN; INFECTION COMPLICATION; LETTER; METASTASIS; MIGRAINE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA FOVEA; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR REGRESSION; VISUAL ACUITY;

ADENOCARCINOMA; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROID NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; INJECTIONS; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 51649100596     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archophthalmol.2008.2     Document Type: Letter

References (8)

1. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36(4):331-335.
2. Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularization secondary to pathologic myopia. Br J Ophthalmol. 2007;91(2):157-160.
3. Sakaguchi H, Ikuno Y, Gomi F, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol. 2007;91(2):161-165.
4. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina. 2006;26(3):352-354.
5. Bakri SJ, Donaldson JM, Link TP. Rapid regression of disc neovascularization in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab. Eye. 2006;20(12):1474- 1475.
6. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina. 2006;26(3):354-356.
7. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26(3):275-278.
8. Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2006;37(2):144-146.